Synergistic Steroidal Saponin and Polyphenol Composition for Neuroprotection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for neurodegenerative diseases like Alzheimer's and Parkinson's lack effective compositions that can be administered with improved patient tolerance and efficacy, with existing compositions often having toxic concentrations of active compounds.
Innovation Solution
A combination composition comprising a steroidal saponin and one or two polyphenolic compounds, such as diosgenin, caffeic acid, and ferulic acid, which are synergistically effective in treating neurodegenerative diseases by enhancing neuronal survival and neurite network protection in rat primary cortical neurons.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If higher concentrations of single active compounds are used to improve treatment efficacy, then neuroprotective effect is enhanced, but toxicity increases
Solution Approach 1:
The patent combines multiple active compounds (steroidal saponins, polyphenolic compounds, and other neuroprotective agents) into a single composition. This synergistic combination allows each compound to work together to enhance neuroprotective effects while maintaining lower individual concentrations, thereby reducing toxicity associated with high doses of single compounds.
Solution Approach 2:
The invention creates a composite therapeutic composition containing multiple active ingredients with different mechanisms of action. This composite approach leverages the complementary neuroprotective properties of steroidal saponins (which protect against excitotoxicity), polyphenolic compounds (which provide antioxidant effects), and other agents, achieving superior efficacy at tolerable doses.
2Object-affected harmful factors
If lower concentrations of active compounds are used to reduce toxicity, then patient tolerance improves, but treatment efficacy decreases
Solution Approach 1:
By merging multiple active compounds into a single composition, the patent achieves synergistic effects where the combined neuroprotective action of lower concentrations of each individual compound equals or exceeds the effect of high concentrations of a single compound. This allows dose reduction while maintaining efficacy.
Solution Approach 2:
The invention changes the concentration parameters of individual compounds within the composition, optimizing each component's dosage to achieve therapeutic effect while staying below toxic thresholds. The synergistic interaction allows the system to achieve high efficacy at optimized, lower individual concentrations.
3Ease of operation
If single compound treatments are used to simplify administration, then ease of operation is improved, but treatment efficacy is limited
Solution Approach 1:
The patent merges multiple active compounds into a single combined composition, maintaining administration simplicity while dramatically improving treatment efficacy. The synergistic combination of steroidal saponins, polyphenolic compounds, and other neuroprotective agents provides multi-mechanistic protection against neurodegeneration, overcoming the limitations of single-compound treatments.
Solution Approach 2:
The invention formulates a composite medication containing multiple active ingredients that work through different mechanisms (excitotoxicity protection, antioxidant activity, anti-inflammatory effects). This composite approach delivers superior therapeutic outcomes while maintaining the ease of single-administration benefit.
Data Source
AI summary
A combination composition including as active components, in synergistically effective amounts of (i) a steroidal saponin of natural or synthetic origin, a pharmaceutical acceptable salt thereof or a plant extract containing steroidal saponin, and (ii) at least a first polyphenolic compound selected from the group of hydroxycinnamic acids, flavonoids, hydroxybenzoic acids, and (iii) optionally, a second polyphenolic compound, wherein the second polyphenolic compound is hydroxycinnamic acids and its use in preventing, inhibiting, retarding or treating a subject suffering from a neurodegenerative disease or condition.